UX111

Abeona Congratulates Ultragenyx on FAYUVI FDA Approval

CLEVELAND, Ohio — September 18, 2026 Abeona Therapeutics congratulated Ultragenyx Pharmaceutical on the U.S. FDA approval of FAYUVI™ (rebisufligene...

By cGxPwire Editor
September 23, 2026

Bio-Pharma

Ultragenyx Advances UX111 Gene Therapy Toward Approval

NOVATO, Calif., April 2, 2026 Ultragenyx Pharmaceutical Inc. has reached a significant regulatory milestone as the U.S. Food and...

By cGxPwire Editor
April 3, 2026

Bio-Pharma

Ultragenyx Gene Therapy Shows Durable Gains in MPS IIIA

NOVATO, Calif., February 3, 2026 — Ultragenyx Pharmaceutical Inc. has reported positive long-term clinical data for UX111, an investigational...

By cGxPwire Editor
February 4, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Abeona Congratulates Ultragenyx on FAYUVI FDA Approval

Ultragenyx Advances UX111 Gene Therapy Toward Approval

Ultragenyx Gene Therapy Shows Durable Gains in MPS IIIA